Function and Regulation of Islet-associated Macrophages in Obesity and Diabetes

肥胖和糖尿病中胰岛相关巨噬细胞的功能和调节

基本信息

项目摘要

DESCRIPTION (provided by applicant): The applicant's career goal is to develop a multidisciplinary research program focused on defining how inflammation contributes to the development of metabolic disease. Emerging data from the past decade has revealed that obesity-induced metabolic inflammation is a key driving force in the pathogenesis of Type 2 diabetes mellitus (T2DM). In the adipose tissue, liver, and muscle, it is well recognized that obesity leads to progressive infiltration of activated pro-inflammatory macrophages and other leukocytes that act in concert to induce insulin resistance and metabolic dysfunction. At present, relatively little is known about whether and how islet-associated macrophages contribute to islet inflammation, glucose intolerance, and beta cell dysfunction in T2DM. Furthermore, the phenotype, function, and regulation of islet-associated macrophages during the progression of metabolic inflammation and T2DM have yet to be fully defined, leaving critical gaps in our understanding of the pathogenesis of this serious metabolic disease. The central hypothesis of this application is that obesity-induced metabolic stress causes the accumulation of pro-inflammatory macrophages within the islet that exacerbate beta cell dysfunction in T2DM. To test this hypothesis and to begin to uncover the role of islet-associated macrophages in the progression of T2DM, three Specific Aims are proposed. Aim 1 will determine the immunophenotype and inflammatory profile of islet-associated macrophages during the progression of glucose intolerance and T2DM in mouse models. Aim 2 will define the interplay between beta cell endoplasmic reticulum (ER) stress and recruitment and activation of islet-associated macrophages. Aim 3 will investigate the effects of pro-inflammatory macrophages on beta cell secretory function in obesity and T2DM. The diverse experimental approaches outlined in the research plan will allow the applicant to broaden his diabetes expertise by developing new proficiencies and complementary skill sets in the assessment of beta cell function in mouse models, isolated islets, and commonly used beta cell lines. The applicant will benefit from training in the Basic Diabetes Research Group within the Herman B Wells Center for Pediatric Research at the Indiana University School of Medicine, which houses five laboratories that are committed to understanding the molecular mechanisms that lead to the development of all forms of diabetes mellitus. This new training in islet biology will complement the applicant's previous training in physiology, metabolism, and obesity-induced inflammation. A diverse team of established investigators will oversee the applicant's career development during the award period by contributing intellectually to his research training, providing mentorship, and offering career advice.
描述(由申请人提供):申请人的职业目标是开发一个多学科的研究计划,重点是定义炎症如何有助于代谢疾病的发展。过去十年的新数据显示,肥胖诱导的代谢性炎症是2型糖尿病(T2DM)发病机制的关键驱动力。在脂肪组织、肝脏和肌肉中,众所周知,肥胖导致活化的促炎性巨噬细胞和其他白细胞的进行性浸润,这些巨噬细胞和其他白细胞协同作用以诱导胰岛素抵抗和代谢功能障碍。目前,对胰岛相关巨噬细胞是否以及如何在T2DM中促进胰岛炎症、葡萄糖耐受不良和β细胞功能障碍知之甚少。此外,代谢性炎症和T2DM进展过程中胰岛相关巨噬细胞的表型、功能和调节尚未完全确定,这使得我们对这种严重代谢性疾病的发病机制的理解存在重大空白。本申请的中心假设是肥胖诱导的代谢应激导致促炎性巨噬细胞在胰岛内积聚,从而加剧T2DM中的β细胞功能障碍。为了检验这一假设并开始揭示胰岛相关巨噬细胞在T2 DM进展中的作用,提出了三个具体目标。目的1研究糖耐量异常和2型糖尿病小鼠模型中胰岛相关巨噬细胞的免疫表型和炎症反应。目的2将明确β细胞内质网(ER)应激与胰岛相关巨噬细胞的募集和激活之间的相互作用。目的3探讨促炎性巨噬细胞对肥胖和2型糖尿病患者β细胞分泌功能的影响。研究计划中概述的各种实验方法将使申请人能够通过开发新的专业和互补技能来扩展其糖尿病专业知识,以评估小鼠模型,分离胰岛和常用β细胞系中的β细胞功能。申请人将受益于印第安纳州大学医学院赫尔曼B威尔斯儿科研究中心基础糖尿病研究组的培训,该中心设有五个实验室,致力于了解导致所有形式糖尿病发展的分子机制。这种胰岛生物学的新培训将补充申请人以前在生理学,代谢和肥胖引起的炎症方面的培训。一个由成熟的调查人员组成的多元化团队将在奖励期间通过为他的研究培训做出智力贡献,提供指导和提供职业建议来监督申请人的职业发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David L Morris其他文献

David L Morris的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David L Morris', 18)}}的其他基金

Function and Regulation of Islet-associated Macrophages in Obesity and Diabetes
肥胖和糖尿病中胰岛相关巨噬细胞的功能和调节
  • 批准号:
    9028604
  • 财政年份:
    2013
  • 资助金额:
    $ 10.9万
  • 项目类别:
Function and Regulation of Islet-associated Macrophages in Obesity and Diabetes
肥胖和糖尿病中胰岛相关巨噬细胞的功能和调节
  • 批准号:
    8877510
  • 财政年份:
    2013
  • 资助金额:
    $ 10.9万
  • 项目类别:
Function and Regulation of Islet-associated Macrophages in Obesity and Diabetes
肥胖和糖尿病中胰岛相关巨噬细胞的功能和调节
  • 批准号:
    8617401
  • 财政年份:
    2013
  • 资助金额:
    $ 10.9万
  • 项目类别:
Role of CD40 in Obesity-Induced Adipose Tissue Inflammation & Insulin Resistance
CD40 在肥胖引起的脂肪组织炎症中的作用
  • 批准号:
    8124157
  • 财政年份:
    2011
  • 资助金额:
    $ 10.9万
  • 项目类别:
Role of CD40 in Obesity-Induced Adipose Tissue Inflammation & Insulin Resistance
CD40 在肥胖引起的脂肪组织炎症中的作用
  • 批准号:
    8265988
  • 财政年份:
    2011
  • 资助金额:
    $ 10.9万
  • 项目类别:
Role of CD40 in Obesity-Induced Adipose Tissue Inflammation & Insulin Resistance
CD40 在肥胖引起的脂肪组织炎症中的作用
  • 批准号:
    8472491
  • 财政年份:
    2011
  • 资助金额:
    $ 10.9万
  • 项目类别:
SH2-B Regulation of Hypothalamic AgRP/NPY Neurons
SH2-B 对下丘脑 AgRP/NPY 神经元的调节
  • 批准号:
    7431719
  • 财政年份:
    2006
  • 资助金额:
    $ 10.9万
  • 项目类别:
SH2-B Regulation of Hypothalamic AgRP/NPY Neurons
SH2-B 对下丘脑 AgRP/NPY 神经元的调节
  • 批准号:
    7263859
  • 财政年份:
    2006
  • 资助金额:
    $ 10.9万
  • 项目类别:
SH2-B Regulation of Hypothalamic AgRP/NPY Neurons
SH2-B 对下丘脑 AgRP/NPY 神经元的调节
  • 批准号:
    7154925
  • 财政年份:
    2006
  • 资助金额:
    $ 10.9万
  • 项目类别:

相似国自然基金

Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 批准年份:
    2020
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 批准年份:
    2017
  • 资助金额:
    20.0 万元
  • 项目类别:
    青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
  • 批准号:
    81670594
  • 批准年份:
    2016
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
  • 批准号:
    81470791
  • 批准年份:
    2014
  • 资助金额:
    73.0 万元
  • 项目类别:
    面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
  • 批准号:
    81301123
  • 批准年份:
    2013
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
  • 批准号:
    81101529
  • 批准年份:
    2011
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
  • 批准号:
    39500043
  • 批准年份:
    1995
  • 资助金额:
    9.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
  • 批准号:
    10719415
  • 财政年份:
    2023
  • 资助金额:
    $ 10.9万
  • 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
  • 批准号:
    10585802
  • 财政年份:
    2023
  • 资助金额:
    $ 10.9万
  • 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10605856
  • 财政年份:
    2023
  • 资助金额:
    $ 10.9万
  • 项目类别:
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
  • 批准号:
    23K15866
  • 财政年份:
    2023
  • 资助金额:
    $ 10.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
  • 批准号:
    23K08773
  • 财政年份:
    2023
  • 资助金额:
    $ 10.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
  • 批准号:
    10743485
  • 财政年份:
    2023
  • 资助金额:
    $ 10.9万
  • 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
  • 批准号:
    10749797
  • 财政年份:
    2023
  • 资助金额:
    $ 10.9万
  • 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
  • 批准号:
    22K09076
  • 财政年份:
    2022
  • 资助金额:
    $ 10.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
  • 批准号:
    10583516
  • 财政年份:
    2022
  • 资助金额:
    $ 10.9万
  • 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
  • 批准号:
    RGPIN-2019-05371
  • 财政年份:
    2022
  • 资助金额:
    $ 10.9万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了